Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Stopped early · Phase 3

Conditions studied: Renal Disease

In brief

The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.

Key facts

Study ID

NCT00980681

Run by

Guerbet

People needed

13

Starts

2009-09-01

Expected to finish

2010-12-01

Last updated by the study team

2016-05-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, aged more than 18 years
• Strongly suspected of having renal arterial disease
• Scheduled (or to be scheduled) to undergo arterial catheter-based X-ray angiography examination

You may not qualify if…

• Known grade IV or V chronic kidney disease (GFR<30 mL/min/1.73m²)
• Contraindication to MRI
• Acute renal dysfunction within the 6 months preceding Dotarem®-enhanced MRA examination

Where it is running

• Guerbet LLC — Bloomington, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.